Diane Seimetz
Director/Board Member at HUMACYTE, INC.
Profile
Diane Seimetz was the founder of Launch Agency LP, founded in 2003, where she held the title of Creative Director & Principal until 2013.
She is also the founder of MyoPax GmbH, founded in 2022, where she currently holds the title of Director.
Dr. Seimetz's current jobs include Director positions at Children's Advocacy Center of Collin County, Inc., Cumulus Oncology Ltd., and Humacyte, Inc., where she is an Independent Director.
Dr. Seimetz's education includes a doctorate from Ruprecht-Karls-Universität Heidelberg, an undergraduate degree from Universität des Saarlandes, and a graduate degree from the University of Bonn.
Diane Seimetz active positions
| Companies | Position | Start |
|---|---|---|
| HUMACYTE, INC. | Director/Board Member | 09/06/2022 |
Children's Advocacy Center of Collin County, Inc.
 Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Director/Board Member | - |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | - |
MyoPax GmbH
 MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Founder | 01/01/2022 |
Former positions of Diane Seimetz
| Companies | Position | End |
|---|---|---|
Launch Agency LP
 Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Founder | - |
Training of Diane Seimetz
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Universität des Saarlandes | Undergraduate Degree |
| University of Bonn | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Children's Advocacy Center of Collin County, Inc.
Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Health Services |
Launch Agency LP
Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Commercial Services |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
MyoPax GmbH
MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Health Technology |
- Stock Market
- Insiders
- Diane Seimetz
